Watch for revenue bumps as majority of ASP drug prices increase in third quarter
You’ll see more money starting July 1 for most of the drugs paid under Medicare’s average sales price (ASP) payment formula, according to a Part B News analysis of the pricing file released by CMS.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.